| scholarly article | Q13442814 |
| P356 | DOI | 10.1136/GUT.33.11.1572 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC1379549 |
| https://europepmc.org/articles/PMC1379549?pdf=render | ||
| https://gut.bmj.com/content/gutjnl/33/11/1572.full.pdf | ||
| https://syndication.highwire.org/content/doi/10.1136/gut.33.11.1572 | ||
| P932 | PMC publication ID | 1379549 |
| P698 | PubMed publication ID | 1280611 |
| P5875 | ResearchGate publication ID | 21874315 |
| P2093 | author name string | M. K. Müller | |
| B. M. Peskar | |||
| M. Rünzi | |||
| J. von Schönfeld | |||
| P2860 | cites work | Studies on the immunosuppressive properties of cyclosporin a in rats receiving renal allografts | Q72134584 |
| Immunological and pharmacological monitoring in the clinical use of cyclosporin A | Q72458883 | ||
| Pancreatic Islet-Acinar Cell Interaction: Amylase Messenger RNA Levels Are Determined By Insulin | Q72637566 | ||
| Effects of cyclooxygenase inhibition on prostaglandin production and insulin and glucagon secretion by isolated rat islets | Q72784000 | ||
| A role for prostaglandins as mediators of alpha-adrenergic inhibition of the acute insulin response to glucose | Q72851904 | ||
| Determination of amylase activity in biological fluids | Q74146570 | ||
| Protein measurement with the Folin phenol reagent | Q20900776 | ||
| Clinical Aspects of Cyclosporine Therapy: A Summation | Q34391899 | ||
| The P450 superfamily: updated listing of all genes and recommended nomenclature for the chromosomal loci | Q38618586 | ||
| Toxicological evaluation of cyclosporin A. | Q40155197 | ||
| The prostaglandin system and insulin release. Studies with the isolated perfused rat pancreas | Q41071822 | ||
| Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes. | Q41176129 | ||
| Interactions between cyclosporin A, indomethacin and 16,16-dimethyl prostaglandin E2: effects on renal, hepatic and gastrointestinal toxicity in the rat. | Q41560578 | ||
| Impairment of stimulated insulin release from the isolated perfused rat pancreas by cyclosporine pretreatment | Q41788721 | ||
| Effects of non-steroidal anti-inflammatory drugs on rat gastric mucosal leukotriene C4 and prostanoid release: relation to ethanol-induced injury | Q41853447 | ||
| Differential sensitivity of rat exocrine and endocrine pancreas to cyclosporine | Q41980091 | ||
| PGE2 reduces nephrotoxicity and immunosuppression of cyclosporine in rats | Q42216049 | ||
| Prevention of toxic effects of cyclosporin on pancreatic B-cells of rats by Rioprostil, a new prostaglandin analogue. | Q43194428 | ||
| Effect of 15(R),15-methyl prostaglandin E2 and indomethacin on pancreatic secretion in man. | Q45222082 | ||
| Effects of cyclosporine on glucose tolerance in the rat. | Q51636100 | ||
| Effects of indomethacin on blood flow in the normal pancreas in conscious dogs. | Q51835871 | ||
| Clinical variability of cyclosporine pharmacokinetics in adult and pediatric patients after renal, cardiac, hepatic, and bone-marrow transplants. | Q52552196 | ||
| A comparison of the clinical utility of the radioimmunoassay, high-performance liquid chromatography, and TDx cyclosporine assays in outpatient renal transplant recipients | Q69486587 | ||
| Inhibition of hepatic microsomal drug metabolism by the immunosuppressive agent cyclosporin A | Q69506353 | ||
| The role of drug metabolism in cyclosporine A nephrotoxicity | Q69510116 | ||
| The role of eicosanoids in cyclosporine nephrotoxicity in the rat | Q69636087 | ||
| The effects of cyclosporin A (CsA) on hepatic microsomal drug metabolism in the rat | Q69877163 | ||
| Amelioration of cyclosporin-induced nephrotoxicity in rats by induction of hepatic drug metabolism | Q70056988 | ||
| Glucose-Dependent Insulinotropic Action of Cholecystokinin Octapeptide in the Isolated Perfused Rat Pancreas | Q70180135 | ||
| A role for endogenous prostaglandins in defective glucose potentiation of nonglucose insulin secretagogues in diabetics | Q70183740 | ||
| Effect of secretin and caerulein in canine pancreas: relation to prostaglandins | Q70261223 | ||
| Chronic cyclosporine A treatment reduces prostaglandin E2 formation in isolated glomeruli and papilla of rat kidneys | Q70288878 | ||
| Are the decreases in hepatic cytochrome P-450 and other drug-metabolising enzymes caused by indomethacin in vivo mediated by intestinal bacterial endotoxins? 16,16-Dimethylprostaglandin F2 alpha prevents decreases in hepatic drug-metabolising enzyme | Q70337429 | ||
| Cyclosporine-associated chronic nephropathy | Q70376376 | ||
| Cyclosporin A and renal prostaglandin biosynthesis | Q70377645 | ||
| Morphological and functional changes of pancreatic B cells in cyclosporin A-treated rats | Q70395421 | ||
| Arachidonic acid metabolism in isolated pancreatic islets. II. The effects of glucose and of inhibitors of arachidonate metabolism on insulin secretion and metabolite synthesis | Q70483481 | ||
| Serum cyclosporin levels, hepatic drug metabolism and renal tubulotoxicity | Q70612490 | ||
| Effects of indomethacin on acute insulin release in man | Q71504155 | ||
| Impaired insulin secretion in human diabetes mellitus. II. A possible role for prostaglandins | Q71543768 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| cyclosporine | Q367700 | ||
| P304 | page(s) | 1572-1577 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Gut | Q5621669 |
| P1476 | title | Importance of endogenous prostaglandins for the toxicity of cyclosporin A to rat endocrine and exocrine pancreas? | |
| P478 | volume | 33 |
Search more.